Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 HKD | -6.15% | -4.69% | -15.28% |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 616 | 560 | 396 | 320 | 332 | 300 |
Enterprise Value (EV) 1 | 516.4 | 437.5 | 296.5 | 217.1 | 307.1 | 264.3 |
P/E ratio | 14.6 x | 14.4 x | 12.9 x | 5.24 x | 5.66 x | 6.39 x |
Yield | 1.62% | 3.57% | 5.05% | 3.13% | 9.04% | 10% |
Capitalization / Revenue | 7.22 x | 6.85 x | 5.18 x | 2.89 x | 2.35 x | 2.35 x |
EV / Revenue | 6.05 x | 5.35 x | 3.88 x | 1.96 x | 2.17 x | 2.07 x |
EV / EBITDA | 9.85 x | 9.12 x | 7.85 x | 2.91 x | 4.13 x | 4.32 x |
EV / FCF | 33.8 x | 14.6 x | 7.64 x | 6.73 x | 3.63 x | 8.79 x |
FCF Yield | 2.96% | 6.87% | 13.1% | 14.9% | 27.5% | 11.4% |
Price to Book | 5.11 x | 3.73 x | 2.58 x | 1.64 x | 1.58 x | 1.35 x |
Nbr of stocks (in thousands) | 400,000 | 400,000 | 400,000 | 400,000 | 400,000 | 400,000 |
Reference price 2 | 1.540 | 1.400 | 0.9900 | 0.8000 | 0.8300 | 0.7500 |
Announcement Date | 8/30/18 | 10/11/19 | 9/29/20 | 10/22/21 | 10/24/22 | 10/24/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 85.32 | 81.76 | 76.44 | 110.8 | 141.4 | 127.8 |
EBITDA 1 | 52.4 | 47.95 | 37.76 | 74.69 | 74.34 | 61.18 |
EBIT 1 | 51.87 | 47.07 | 35.53 | 73.18 | 73.12 | 59.86 |
Operating Margin | 60.8% | 57.57% | 46.48% | 66.04% | 51.71% | 46.83% |
Earnings before Tax (EBT) 1 | 50.97 | 47.12 | 36.18 | 73.48 | 72.44 | 58.67 |
Net income 1 | 42.22 | 38.92 | 30.69 | 61.02 | 58.62 | 46.92 |
Net margin | 49.48% | 47.6% | 40.15% | 55.07% | 41.46% | 36.71% |
EPS 2 | 0.1056 | 0.0973 | 0.0767 | 0.1526 | 0.1466 | 0.1173 |
Free Cash Flow 1 | 15.27 | 30.04 | 38.81 | 32.26 | 84.58 | 30.08 |
FCF margin | 17.9% | 36.74% | 50.77% | 29.11% | 59.82% | 23.53% |
FCF Conversion (EBITDA) | 29.15% | 62.65% | 102.77% | 43.19% | 113.77% | 49.17% |
FCF Conversion (Net income) | 36.17% | 77.18% | 126.45% | 52.86% | 144.29% | 64.11% |
Dividend per Share 2 | 0.0250 | 0.0500 | 0.0500 | 0.0250 | 0.0750 | 0.0750 |
Announcement Date | 8/30/18 | 10/11/19 | 9/29/20 | 10/22/21 | 10/24/22 | 10/24/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 99.6 | 122 | 99.5 | 103 | 24.9 | 35.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 15.3 | 30 | 38.8 | 32.3 | 84.6 | 30.1 |
ROE (net income / shareholders' equity) | 38.6% | 28.8% | 20.2% | 35.1% | 28.9% | 21.7% |
ROA (Net income/ Total Assets) | 23.4% | 17.7% | 12.2% | 21.6% | 15.4% | 10.7% |
Assets 1 | 180.4 | 220.4 | 250.8 | 282 | 379.8 | 437.8 |
Book Value Per Share 2 | 0.3000 | 0.3700 | 0.3800 | 0.4900 | 0.5300 | 0.5600 |
Cash Flow per Share 2 | 0.2400 | 0.3000 | 0.2500 | 0.1400 | 0.2200 | 0.2300 |
Capex 1 | 0.88 | 0.21 | 2.62 | 0.02 | 15.7 | 0.26 |
Capex / Sales | 1.03% | 0.26% | 3.43% | 0.02% | 11.13% | 0.2% |
Announcement Date | 8/30/18 | 10/11/19 | 9/29/20 | 10/22/21 | 10/24/22 | 10/24/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-15.28% | 33.51M | |
+30.30% | 75.6B | |
+6.17% | 45.71B | |
-9.63% | 5.4B | |
+2.14% | 2.2B | |
-28.30% | 1.8B | |
+9.20% | 1.51B | |
+0.57% | 1.41B | |
-11.79% | 1.13B | |
-33.45% | 1.07B |
- Stock Market
- Equities
- 2293 Stock
- Financials Bamboos Health Care Holdings Limited